Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022594
Status:
COMPLETED
Last Update Posted:
2012-07-24
First Post:
2001-08-10
Brief Title:
Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC
Organization:
European Organisation for Research and Treatment of Cancer - EORTC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent metastatic squamous neck cancer with occult primary | View |
| metastatic squamous neck cancer with occult primary squamous cell carcinoma | View |
| stage III squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| stage III squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| stage III squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| stage III squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the larynx | View |